Obagi Medical Products
Valeant takes huge loss on previous deal to pay down debts
July 18, 2017Manufacturing and Production, Sales and Marketing Obagi Medical Products, Valeant, biotech, drugs, pharma, pharmaceutical
It is an odd time for Valeant, where selling a part of its business for half of what it paid, …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
